Teriparatide [RHPTH (1-34)] treatment reduces the incidence of back pain in postmenopausal women with osteoporosis

被引：0
|
作者：
Krege, JH
Xie, L
Genant, HK
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] UCSF, San Francisco, CA USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of Teriparatide (rhPTH[1-34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
    Satterwhite, Julie
    Heathman, Michael
    Miller, Paul D.
    Marin, Fernando
    Glass, Emmett V.
    Dobnig, Harald
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (06) : 485 - 492
  • [2] Teriparatide (rhPTH [1-34]) treatment improves the structure of the proximal femur in women with osteoporosis.
    Semanick, LM
    Uusi-Rasi, K
    Zanchetta, JR
    Bogado, CE
    Eriksen, EF
    Sato, M
    Beck, TJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S40 - S40
  • [3] Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    Slavakis, Aristides
    Efstathiadou, Zoe
    Kita, Marina
    Koukoulis, George
    Avramidis, Avraam
    [J]. ENDOCRINE JOURNAL, 2008, 55 (03) : 613 - 616
  • [4] Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
    Julie Satterwhite
    Michael Heathman
    Paul D. Miller
    Fernando Marín
    Emmett V. Glass
    Harald Dobnig
    [J]. Calcified Tissue International, 2010, 87 : 485 - 492
  • [5] The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis
    Genant, HK
    Halse, J
    Briney, WG
    Xie, L
    Glass, EV
    Krege, JH
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) : 1027 - 1034
  • [6] Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1-34)] in Postmenopausal Osteoporosis
    Cosman, Felicia
    Eriksen, Erik Fink
    Recknor, Chris
    Miller, Paul D.
    Guanabens, Nuria
    Kasperk, Christian
    Papanastasiou, Philemon
    Readie, Aimee
    Rao, Hanumantha
    Gasser, Juerg A.
    Bucci-Rechtweg, Christina
    Boonen, Steven
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 503 - 511
  • [7] The rhPTH (1-34), But not Elcatonin, Increases Bone Anabolic Efficacy in Postmenopausal Women with Osteoporosis
    Zhang, L.
    Yang, M.
    Liu, D.
    Guo, C.
    Li, L.
    Yang, G.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (06) : 361 - 366
  • [8] Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis
    Adami, S.
    Martin, J. San
    Munoz-Torres, M.
    Econs, M. J.
    Xie, L.
    Dalsky, G. P.
    McClung, M.
    Felsenberg, D.
    Brown, J. P.
    Brandi, M. L.
    Sipos, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (01) : 87 - 94
  • [9] Teriparatide -: rhPTH(1-34) -: LY-333334 -: Forteo® -: Treatment of osteoporosis -: Parathyroid hormone
    不详
    [J]. DRUGS OF THE FUTURE, 2001, 26 (08) : 824 - 827
  • [10] Back Pain is Reduced in Postmenopausal Women with Severe Osteoporosis Treated with rhPTH(1-34) (teriparatide) Regardless of Incident Fractures: 18 Month Results from the European Forsteo Observational Study (EFOS).
    Ljunggren, Oe
    Fahrleitner-Pammer, A.
    Kutahov, A.
    Walsh, J. B.
    Langdahl, B.
    Jakob, F.
    Lems, W.
    Rajzbaum, G.
    Barker, C.
    Karras, D.
    Marin, F.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S347 - S347
12345